Genitourinary Cancers | Tumor

Presurgical Cetrelimab With TAR-200 Shows Responses in Muscle-Invasive Bladder Cancer

September 16th 2024, 10:00pm

Article

Patients with muscle-invasive bladder cancer who were treated with presurgical chemotherapy may have a 55% lower risk of death, research shows.

Welireg Shows Stable Survival Benefits Over Afinitor in Kidney Cancer

September 13th 2024, 9:00pm

Article

Among patients with previously treated advanced clear cell renal cell carcinoma (RCC) Welireg continued to show some benefits, though not to overall survival.

Princess Kate Finishes Chemo, E Street Band Member Announces Diagnosis and More

September 13th 2024, 3:00pm

Article

From Princess Kate entering ‘a new phase of recovery’ to a Rock and Roll Hall of Famer’s blood cancer announcement, here’s what’s happening in the cancer space this week.

Take Life On: My Mantra After Cancer

August 29th 2024, 5:00pm

Article

I stopped pondering why cancer happened to me and instead focused on achieving my goals and taking life on.

Focusing Energy on Cancer-Related Fatigue

August 26th 2024, 7:00pm

Article

Fatigue is a common side effect that may linger for years following cancer treatment. Experts and survivors talk about ways to help find a balance between life and fatigue.

Danielle Fishel of ‘Boy Meets World’ Has Cancer, ‘Emily in Paris’ Star Discusses Her Diagnosis and More

August 23rd 2024, 3:00pm

Article

From Danielle Fishel and Rick Steves announcing their diagnosis to the “Emily in Paris” star discussing her cancer experience, here’s what’s happening in the oncology space this week.

What Patients With Kidney Cancer Need to Know About Welireg

August 23rd 2024, 1:00pm

Article

One expert explained why ‘it’s very important to know what’s going on’ with regard to new renal cell carcinoma treatments.

ARPIs May Improve Survival in Some With Prostate Cancer

August 22nd 2024, 9:00pm

Article

Androgen receptor pathway inhibitors were shown to better treat patients with metastatic castration-resistant prostate cancer and improved survival.

Afinitor May Not Boost Outcomes in Non-Clear Cell Kidney Cancer

August 22nd 2024, 3:00pm

Article

Afinitor did not improve relapse-free survival in patients with non-clear cell renal cell carcinoma — a kidney cancer subtype linked to poor prognosis.

Dose-Dense Chemo for Muscle-Invasive Bladder Cancer May Be Feasible

August 14th 2024, 3:34pm

Article

Patients with locally advanced muscle-invasive bladder cancer may benefit from dose-dense gemcitabine and cisplatin.